This study is stage 2, round 1 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
This study is stage 2, rapid response testing (RRT), of the optimization phase of a larger study which refines and optimizes the EMBED\* clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder. Investigators will use a Multiphase Optimization Strategy (MOST) framework study with preparation, optimization, and confirmatory phases. In stage 2 optimization phase, investigators will conduct serial rapid-cycle randomized testing to inform iterative refinement of the CDS interface and workflow to minimize user errors, task disruption, and abandonment through identification of specific targets for improvement via application of novel CDS outcome measures with the goal of improving CDS usability. Five rounds of A-B testing are expected. The more successful condition will be tested in the subsequent round against a novel test condition. In this first round we will test the placement of the nurse prompt to complete COWS randomizing encounters to place the prompt under either required or optional documentation. Future rounds will be planned, with arms and interventions added, as the project progresses in order to build on insights gained in each round. Phase 3, the evaluation phase, will consist of a randomized trial of the optimized package compared to the original EMBED and the evaluation phase in which investigators will compare the efficacy of the optimized, multicomponent CDS package to the original EMBED CDS on ED-initiation of buprenorphine rates in patients with OUD in a randomized trial. \*EMBED is a user centered, clinician facing clinical decision support system integrated into the electronic health record workflow to facilitate initiating buprenorphine in the emergency department by: diagnosing opioid use disorder with a checklist based on the diagnostic criteria of the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition), assessing the severity of withdrawal with the Clinical Opioid Withdrawal Scale (COWS), motivating patients to accept treatment with a scripted brief negotiation interview, and automating the electronic health record workflow, including clinical and after visit documentation, order entry, prescribing, and referral for ongoing treatment in the community This study does not have open enrollment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
267
Nurse receives prompt to complete COWS under required documentation
Refined EMBED CDS
Yale New Haven Shoreline Medical Center
Guilford, Connecticut, United States
Yale New Haven Hospital- St. Raphael
New Haven, Connecticut, United States
Yale New Haven Hospital
New Haven, Connecticut, United States
Proportion of encounters with COWS completed
Proportion of eligible encounters with a COWS competed, by any team member and via any workflow (internal and external of EMBED). Obtained from EHR data.
Time frame: Trial round start to end up to 3 months
Proportion of encounters with Buprenorphine initiation in the ED
Proportion of eligible encounters with buprenorphine administered in the Emergency Department (ED) and/or prescribed buprenorphine on discharge from the ED. Obtained from EHR data.
Time frame: Trial round start to end up to 3 months
Proportion of eligible encounters with CDS engagement
Proportion of eligible encounters in which any portion of the EMBED workflow was documented or completed.
Time frame: Trial round start to end up to 3 months
Teamwork on CDS Engagement
Proportion of eligible encounters in which more than one team member (regardless of role) helped complete the EMBED workflow.
Time frame: Trial round start to end up to 3 months
Proportion of eligible users who used EMBED
Proportion of EM staff members (Attendings, Residents and APPS) who cared for at least patient for whom the alert fired during the study period who used EMBED at least once during the study period.
Time frame: Trial round start to end up to 3 months
Proportion of encounters in which buprenorphine was ordered through EMBED vs. externally.
Proportion of eligible encounters in which buprenorphine order is placed through EMBED (i.e., using EMBED order set)
Time frame: Trial round start to end up to 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time spent on EMBED
Time (in seconds) spent on EMBED overall and by component.
Time frame: Trial round start to end up to 3 months
Task Completion: Proportion of encounters with OUD diagnosis was recorded
Proportion of encounters where EMBED was opened in which the OUD diagnosis was recorded
Time frame: Trial round start to end up to 3 months
Task Completion: Proportion of Encounters with COWS Score Entered
Proportion of encounters where EMBED was opened in which a COWS score was entered.
Time frame: Trial round start to end up to 3 months
Task completion: Buprenorphine order or prescription placed
Proportion of encounters where EMBED was opened in which a buprenorphine order or prescription was placed.
Time frame: Trial round start to end up to 3 months